Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cangfu Ovulation Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its efficacy in treating infertility associated with Polycystic Ovary Syndrome (PCOS) and obesity. Developed by researchers at Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, the decoction is based on traditional principles aimed at resolving phlegm-dampness and blood stasis, which are believed to impede ovulation. The formula is typically used to regulate reproductive hormones, improve insulin sensitivity, and promote follicular maturation. Clinical studies, including randomized controlled trials registered in the Chinese Clinical Trial Registry (ChiCTR), have evaluated its impact on ovulation rates and pregnancy outcomes in overweight women with ovulatory dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cangfu ovulation decoction.